JAAD Dupilumab & Psoriasis Risk Brief Report

Published: 25 March 2026| Version 3 | DOI: 10.17632/p785bcpmkg.3
Contributor:
Brandon Block

Description

Supplementary materials for a brief report entitled "Dupilumab and psoriasis risk in patients with atopic dermatitis: A multicenter cohort study," to be submitted to JAAD

Files

Categories

Dermatology, Biologic Agent, Atopic Dermatitis, Psoriasis

Licence